Update July 24,2024:
"About 80 people are involved in the trial at MaineHealth’s Pen Bay Medical Center, which is part of a national study of a Lyme vaccine called VLA15 developed by the companies Pfizer and Valneva, according to Dr. Robert Smith, who’s working on the trial team. In total, the study is testing the safety and effectiveness of the shot on nearly 9,500 people across the country.
...
The goal is for the vaccine to show a statistically significant decline in cases of Lyme disease. Smith said the trials are expected to conclude by the end of 2025, which is when Pfizer